M-BACOD regimen: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} {{SK}} m-BACOD Regimen; Methotrexate-Bleomycin-Adriamycin-Cytoxan-Oncovin-Decadron Regimen ==Overview== {{PAGENAME}} refers to a regi..." |
No edit summary |
||
| Line 10: | Line 10: | ||
==Regimen== | ==Regimen== | ||
{{chemo|M|Methotrexate}} | {{chemo|M|Methotrexate}} | ||
{{chemo|B|Bleomycin}} | {{chemo|B|Bleomycin}} | ||
{{chemo|A|Doxorubicin (Adriamycin)}} | {{chemo|A|Doxorubicin (Adriamycin)}} | ||
{{chemo|C|Cyclophosphamide}} | {{chemo|C|Cyclophosphamide}} | ||
| Line 21: | Line 22: | ||
==Indications== | ==Indications== | ||
*[[non-Hodgkin's lymphoma]]<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63458&ns=NCI_Thesaurus}}</ref><ref name="pmid1688615">{{cite journal| author=Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS et al.| title=The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen. | journal=J Clin Oncol | year= 1990 | volume= 8 | issue= 1 | pages= 84-93 | pmid=1688615 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1688615 }} </ref> | *[[non-Hodgkin's lymphoma]]<ref>{{Cite web | title = NCI Thesaurus | accessdate = | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C63458&ns=NCI_Thesaurus}}</ref><ref name="pmid1688615">{{cite journal| author=Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS et al.| title=The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen. | journal=J Clin Oncol | year= 1990 | volume= 8 | issue= 1 | pages= 84-93 | pmid=1688615 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1688615 }} </ref> | ||
| Line 27: | Line 27: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Chemotherapy regimens]] | [[Category:Chemotherapy regimens]] | ||
Latest revision as of 15:23, 27 March 2015
|
WikiDoc Resources for M-BACOD regimen |
|
Articles |
|---|
|
Most recent articles on M-BACOD regimen Most cited articles on M-BACOD regimen |
|
Media |
|
Powerpoint slides on M-BACOD regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on M-BACOD regimen at Clinical Trials.gov Trial results on M-BACOD regimen Clinical Trials on M-BACOD regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on M-BACOD regimen NICE Guidance on M-BACOD regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on M-BACOD regimen Discussion groups on M-BACOD regimen Patient Handouts on M-BACOD regimen Directions to Hospitals Treating M-BACOD regimen Risk calculators and risk factors for M-BACOD regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for M-BACOD regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: m-BACOD Regimen; Methotrexate-Bleomycin-Adriamycin-Cytoxan-Oncovin-Decadron Regimen
Overview
M-BACOD regimen refers to a regimen consisting of methotrexate, bleomycin, doxorubicin (adriamycin), cyclophosphamide, vincristine and dexamethasone used to treat aggressive forms of non-Hodgkin's lymphoma.[1][2]
Regimen
MMethotrexate
BBleomycin
ADoxorubicin (Adriamycin)
CCyclophosphamide
OVincristine (Oncovin)
DDexamethasone
Indications
References
- ↑ "NCI Thesaurus".
- ↑ 2.0 2.1 Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS; et al. (1990). "The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen". J Clin Oncol. 8 (1): 84–93. PMID 1688615.
- ↑ "NCI Thesaurus".